- Home
- TBRG vs ZYXI Comparison
TBRG vs ZYXI Comparison
Compare TBRG & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBRG
- ZYXI
- Stock Information
- Founded
- TBRG 1979
- ZYXI 1996
- Country
- TBRG United States
- ZYXI United States
- Employees
- TBRG N/A
- ZYXI N/A
- Industry
- TBRG
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TBRG
- ZYXI Health Care
- Exchange
- TBRG NYSE
- ZYXI Nasdaq
- Market Cap
- TBRG 271.5M
- ZYXI 261.5M
- IPO Year
- TBRG N/A
- ZYXI N/A
- Fundamental
- Price
- TBRG $23.34
- ZYXI $8.14
- Analyst Decision
- TBRG Buy
- ZYXI Strong Buy
- Analyst Count
- TBRG 3
- ZYXI 2
- Target Price
- TBRG $14.67
- ZYXI $14.00
- AVG Volume (30 Days)
- TBRG 90.5K
- ZYXI 74.7K
- Earning Date
- TBRG 02-27-2025
- ZYXI 02-27-2025
- Dividend Yield
- TBRG N/A
- ZYXI N/A
- EPS Growth
- TBRG N/A
- ZYXI N/A
- EPS
- TBRG N/A
- ZYXI 0.15
- Revenue
- TBRG $337,674,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- TBRG $1.02
- ZYXI $10.70
- Revenue Next Year
- TBRG $6.06
- ZYXI $19.78
- P/E Ratio
- TBRG N/A
- ZYXI $54.95
- Revenue Growth
- TBRG 0.26
- ZYXI 4.21
- 52 Week Low
- TBRG $7.55
- ZYXI $7.15
- 52 Week High
- TBRG $23.64
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- TBRG 83.06
- ZYXI 52.72
- Support Level
- TBRG $20.62
- ZYXI $7.57
- Resistance Level
- TBRG $23.32
- ZYXI $8.26
- Average True Range (ATR)
- TBRG 0.82
- ZYXI 0.27
- MACD
- TBRG 0.19
- ZYXI 0.00
- Stochastic Oscillator
- TBRG 93.96
- ZYXI 84.21
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.